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Role of peripheral immune response in microglia activation and
regulation of brain chemokine and proinflammatory cytokine
responses induced during VSV encephalitis
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Sanfordb, and Richard P. Ciavarraa,1
aDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School,
Norfolk, VA 23501
bDepartment

of Pathology and Anatomy, Eastern Virginia Medical School, Norfolk, VA 23501
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1. Introduction
Many lethal human pathogens (e.g. rabies, Ebola, and Hendra viruses) can be found in the
Order Mononegavirales. These viruses can also have economic impacts because of their
ability to infect poultry and cattle (D’Agostino et al., 2012b)Lamb and Parks, 2007; Lyles
and Rupprecht, 2007; Planz et al., 2009). Vesicular stomatitis virus (VSV) is a member of
the Vesiculovirus genus in the Rhabdoviridae family, one of the four families in the Order
Mononegavirales and is the prototypic virus of this family that includes rabies virus. The
genome of VSV encodes only five major proteins that nonetheless provide sufficient
information to infect a broad range of host cells, shut down cellular protein synthesis and
produce productive infections (Das et al., 2008). VSV introduced systemically induces a
rapid and potent type I interferon (IFN) response essential for survival (Barchet et al., 2002).
Components of the adaptive immune response (antibody, T cells) appear around 6-8 days
post infection (PI) and eliminate infectious VSV from peripheral tissues. In the absence of
adaptive immunity mice invariably succumb to infection (Thomsen et al., 1997).
Unexpectedly, VSV antigen remains in peripheral tissues for almost two months PI despite
efficient clearance of infectious VSV from the host (Turner et al., 2007).
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A single intranasal application of VSV results in infection and viral replication in olfactory
neurons with transmission of this neurotropic virus to the olfactory bulb (OB) via the
olfactory nerve (Reiss et al., 1998). VSV replicates invasively in the OB penetrating deeper
layers of the OB (Reiss et al., 1998) and progresses caudally reaching the hindbrain around
day 8 (Huneycutt et al., 1994). CNS invasion by VSV does not go unnoticed as Rig-1
(retinoic acid like receptor-1, (Rieder and Conzelmann, 2009) and toll-like receptor-7 (TLR7
(D’Agostino et al., 2012a, Lund et al., 2004) signaling pathways are engaged resulting in
astrocyte and microglia activation and a subsequent astrocytosis and microgliosis (Steel et
al., 2009). Neutrophils are the initial inflammatory cell seen in the OB around 1 day PI
(Chen et al., 2001) suggesting rapid chemokine production, a view supported by elevated
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CCL1 and CXCL10 transcripts in the brain detected one day PI (Ireland and Reiss, 2006).
Around 6-8 days PI a robust mixed cellular infiltrate dominated by neutrophils, T cells,
macrophages and to a lesser extent DCs accumulates in the brain parenchyma (Bi et al.,
1995, Ciavarra et al., 2006, Steel et al., 2009, Steel et al., 2008). A number of studies have
demonstrated that inhibition of VSV replication, caudal penetration and survivability are
dependent on both innate and adaptive effector mechanisms (Huneycutt et al., 1993,
Komatsu et al., 1999, Thomsen et al., 1997). It has previously been suggested that VSV
encephalitis is T cell-independent although this view has not been critically tested during
either the acute (6-8 days PI) or recovery (10-14 days PI) phases of VSV encephalitis (Frei
et al., 1989, Nansen et al., 2000).
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The observed activation and expansion of microglia in encephalitic brains is consistent with
prior studies in autoimmune and inflammation models suggesting that microglia represent
key regulatory cells in the innate and adaptive immune response (Marques et al., 2006, Pope
et al., 1998). Furthermore, microglia are reported to up regulate MHC class II and CCR7 at
the onset of symptoms and progression of experimental allergic encephalomyelitis
collaborating the view that microglia develop into antigen presenting cells (APCs) with
migratory potential in the inflamed CNS (Dijkstra et al., 2006). However, under basal
conditions the brain parenchyma also contains a trace population of CD11c+ cells that may
represent antigen-presenting DCs. Most of these cells reside in the juxtavascular
parenchyma and not the perivascular spaces. Interestingly, their cellular processes extended
into the glia limitans that may allow for presentation of antigens to extravasated T cells in
the perivascular spaces (D’Agostino et al., 2012a). CD11c+ can also be found in the
meninges and choroid plexus and at this location they constitutively express MHC class II
antigens, unlike parenchymal DCs and microglia (Anandasabapathy et al., 2011, D’Agostino
et al., 2012a). In the VSV encephalitis model, both innate and adaptive immune responses
were markedly impaired by prior conditional ablation of peripheral DCs (Steel et al., 2009),
whereas conditional depletion of peripheral macrophages did not alter VSV encephalitis
(Steel et al., 2010). Interestingly, selected depletion of brain perivascular macrophages
(bPVMs) inhibited anti-viral immunity and survival (Steel et al., 2010). Thus the precise
role these various cell types play in the CNS innate and adaptive anti-viral immune response
is poorly defined and remains a contentious issue.
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In this study, we describe phenotypic changes on microglia isolated from encephalitic brains
that argue against these cells functioning as professional APCs although microglia are
clearly activated by VSV. The robust infiltrate characteristic of the acute phase of VSV
encephalitis reflects the rapid (24 hours PI) global induction of transcripts encoding multiple
chemokines and proinflammatory cytokines. Multi-parameter flow cytometric analysis
confirmed that activated microglia expressed two CC receptors (CCR4, CCR9) that could
contribute to their activated state. In contrast, inflammatory cells were devoid of all tested
chemokine receptors with the exception of CCR7. Kinetic analysis revealed that VSVinduced a bimodal chemokine and proinflammatory cytokine mRNA response with a major
peak on day 3 followed by a second weaker induction on 7 days PI. Ablation of peripheral
DCs or T cells markedly inhibited global chemokine and cytokine transcript levels on 7 days
PI. Thus, infiltrating T cells represent not only anti-viral effector cells but may also function
to sustain the inflammatory response until infections virus is cleared from the CNS.

2. Materials and Methods
Mice and virus infection
Diphtheria toxin (DT) receptor transgenic (DTRTg) mice (C.FVB-Tg(Itgax-DTR/
EGFP)57Lan/J, Jackson Laboratories Bar Harbor, ME) were bred to C57BL/6 mice (B6,
Jackson Laboratories). Transgenic F1 mice were used in all DC depletion studies and are
J Neuroimmunol. Author manuscript; available in PMC 2015 February 15.
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referred to as DTRTgF1 mice. b2m-knock out mice (strain B6.129P2-b2m) were purchased
from Jackson Laboratories (Bar Harbor, ME) and housed in our animal facility in sterile
microisolator cages with sterile food, water and bedding. Wild-type VSV-Indiana strain,
provided by Dr. Philip Marcus, University of Connecticut, was grown and assayed as
previously described (Marvaldi et al., 1977). Virus was grown in confluent monolayers of
Vero cells and virus titers determined by standard plaque assays (Sekellick and Marcus,
1979). VSV was introduced into the brain via intranasal application of 5ul/nostril with
5×104 PFU VSV (Barna et al., 1996). All experiments were performed in accordance with
federal guidelines and under an Institutional Animal Care and Use Committee-approved
protocol.
Cell isolation and depletion
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Brains were excised from perfused (30ml cold PBS) mice, individually homogenized,
pooled and then subjected to discontinuous Percoll centrifugation to enrich for microglia and
leukocytes as previously described (Steel et al., 2009). Single cell suspensions of peripheral
organs (spleen, draining cervical lymph nodes (CLNs), lung) were scrubbed through 40m
nylon mesh cell strainers. Erythrocytes were lysed as necessary using BD PharmLyse
Ammonium Chloride lysing reagent (Becton Dickinson, Carlsbad, CA). In vivo ablation of
DCs was achieved in DTRTgF1 mice with DT following an established protocol (Ciavarra
et al., 2006). Depletion of CD4+ cells was achieved in b2m-knock out mice (CD8-deficient
mice). Groups of age-matched mice were treated with anti-mouse CD4 (clone YTS 191, Bio
X Cell, Inc., West Lebonon, NH) to deplete their CD4+ T cells, or with rat IgG2b isotype
control (clone LTF-2, Bio X Cells, Inc.). Mice received 100 ug of anti-CD4 or isotype
control in sterile PBS by intraperitoneal injection on days −3, −1, +1, +3 and were
euthanized on day +7.
Multiparameter Flow Cytometry
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Unless indicated otherwise, monoclonal antibodies (mAbs) against cell surface antigens
were purchased from eBioscience (San Diego, CA). Cells were stained and washed in flow
cytometry wash buffer (PBS supplemented with 1% goat serum and 0.1% sodium azide).
The following mAbs were used in this study: CD11b, clone M1/70; CD45, clone 30-F11;
MHC II, clone M5/114.15.2; CD11c, clone N418; CD4, clone GK1.5; CD8α, clone 53-6.7;
CD45R, clone RA3-6B2; MHC I, clone 34-1-2S; PD-1, clone J43; CD115, clone AFS98;
CD40, clone 1C10; CCR1, clone 643854; CCR2, clone 475301; CCR4, clone 2G12; CCR7,
clone 4B12; CCR9, clone CD-1.2; CXCR3, clone CXCR3-173; and CD80, clone 16-10A1.
Fluorophore conjugates varied based on staining profiles used. Acquisition of 20-200,000
events was performed using a Becton Dickinson (San Diego, CA) FACSCalibur using
FlowJo software (Tree Star, Ashland, OR). Non-specific binding in the absence of additional
Fc block was previously evaluated and did not affect staining patterns. To determine the
absolute number of microglia and infiltrating leukocytes in the CNS, a leukocyte gate was
first defined for these cells based on forward and side scatter characteristics. Preliminary
studies verified that these gated cells were CD45+ and viable (≥95%propidium iodide and
annexin negative). The percentage of microglia (CD45low/int) or infiltrating blood cells
(CD45high) within this gate was then used to calculate cell recoveries. All gates and
quadrants were established with the use of appropriate isotype controls.
RNA profiles
Whole brains were removed following perfusion and homogenized in cold PBS. A volume
equivalent of 20 mg was removed from each brain homogenate and RNA isolated using the
QuickGene RNA tissue kit SII (RT-S2) from FUJIFILM Corporation. RNA profiles were
characterized by real-time PCR on RNA isolated either from individual animals or pooled
RNA depending on the experiment using a commercial inflammatory cytokine array
J Neuroimmunol. Author manuscript; available in PMC 2015 February 15.
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(SABiosciences, catalogue number PAMM-011). Naive (uninfected) mouse brains were
used as controls to calculate fold differences in experimental groups.
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3. Results
Characterization of resident microglia and the cellular infiltrate during the acute phase of
VSV encephalitis
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The function of resident microglia and inflammatory cells that penetrate the brain
parenchyma during VSV encephalitis remains poorly defined. It is also unclear whether the
increased numbers of DCs detected in the encephalitic brain are blod-derived or represent
expansion of resident CD11c+ cells (D’Agostino et al., 2012b). To gain insights into
potential functions of these various cell types we phenotyped microglia isolated from the
brains of uninfected and VSV-infected mice. To determine whether the accumulation of
brain DCs (bDCs) seen during VSV encephalitis reflected infiltration of blood-derived DCs,
peripheral DCs were ablated with DT prior to infection with VSV. At the peak of the
inflammatory response (6-8 days PI), leukocytes were isolated and phenotyped by multicolour flow cytometry. We previously demonstrated VSV infection induced a pronounced
CNS infiltrate of CD45highCD11b+cells that was clearly distinct from resident CD45low/int
CD11b+ microglia (Steel et al., 2009) and Figure 1A). Diphtheria toxin treatment did not
deplete microglia but profoundly suppressed the number of inflammatory cells in the brain
(panel b). Microglia (gated CD45lowCD11b+) isolated from uninfected mice were
CD115+MHC-1−/lowMHC-II-CCR7-CD11c-CD40-CD80-(data not shown). This phenotype
remained stable during infection with the exception of MHC class-I antigens (MHC-1) that
were upregulated indicating that microglia recognized and responded to the presence of this
virus (Figure 1B, panels c, e, g, i). Ablation of peripheral DCs did not alter microglia CD115
(colony stimulating factor receptor-1) expression but suppressed induction of MHC-1
antigens suggesting that optimal microglia activation was dependent on infiltrating DCs (1B,
panels d, f, h, j). MHC class-II antigens were not detected at this time but are expressed in
significant amounts around 10 days PI (Steel et al., 2009). Thus, VSV infection activates
microglia in a CCR7- and CD40/CD154-independent fashion during the acute phase of VSV
encephalitis. The role of constitutive and sustained expression of microglia CD115 during
VSV encephalitis remains to be elucidated. In contrast to microglia, the CD45highCD11b+
infiltrate was primarily CCR7+CD40+CD115+MHC-1+MHC-II±CD80+ irrespective of
whether they were isolated from normal of DC-depleted hosts (1C, panels k-r). Within the
infiltrate gate we detected bDCs (CD11c+CD11b+CCR7+, panels k-j mostly derived from
the circulating pool because prior DT treatment decreased the number of bDCs relative to
untreated VSV infected transgenic mice (3 × 104 versus 0.94 × 104/mouse for untreated and
DT treated, respectively). These data are consistent with recent studies by Bullock and
colleagues (D’Agostino et al., 2012a, D’Agostino et al., 2012b) who reported that in the
VSV encephalitis model one of the major bDC subsets is peripherally derived. As reported
previously, CD4+ and CD8+ T cells were well represented in the infiltrate including a
subset specific for the immunodominant epitope present in the VSV nuclear protein.
Depletion of peripheral DCs markedly inhibited infiltration of both CD4+ and CD8+ T cell
subsets as well as the CD8+ VSV-specific subset (tetramer+).
Evaluation of microglia as antigen presenting cells during the induction phase of VSV
encephalitis
To determine if costimulatory molecules are transiently expressed on activated microglia we
phenotyped microglia for B7 family members as well as 4-1BBL (CD137) at 3 days PI.
DTRTg mice were either untreated or depleted of DCs prior to infection to assess the extent
to which infiltrating DCs contribute to microglia activation and costimulatory antigen
expression. In this study we isolated microglia from the OB where most of the viral antigen
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rapidly accumulates providing microglia with ample viral antigen for T cell activation. As
expected, OB microglia obtained from naïve (uninfected) mice expressed very low levels of
MHC-I antigen and were devoid of MHC-II. In their naïve state they also did not express the
costimulatory molecules CD80, CD86, CD137 and CD154 (CD40 ligand) as well as the B7
family members PD-L1/2 (B7-H1/B7-DC) or PD-1, the receptor for these inhibitory ligands
(Figure 2A, panels a-e). Although microglia from VSV infected OBs became activated
indicated by increased expression of MHC-1 and PD-1, they failed to express any of the
evaluated costimulatory molecules (panels f-j). Again, maximum microglia MHC-1
expression was dependent on peripheral DCs, whereas PD-1 expression was normal in these
mice (panels k-o). This phenotype was not unique to OB microglia because microglia
isolated from the remaining brain also did not express B7 family members (panel B).
Rapid Chemokine and proinflammatory cytokine responses in the CNS following infection
with VSV

NIH-PA Author Manuscript

Prior studies indicated intranasal application of VSV induced a rapid chemokine response
(Ireland and Reiss, 2006) that was followed by the appearance of inflammatory cells
(Mac-1+) in the OB around 36 hours PI (Christian et al., 1996, Ireland and Reiss, 2006). To
more completely characterize this response, we used a focused inflammatory cytokine qPCR
array on OBs from naïve mice and mice infected with VSV one day previously. Figure 3
illustrates that 24 hours PI, several chemokine ligand/receptor pairs were altered by
infection. Generally, there was a co-ordinated induction of receptors and their respective
chemokine ligands. A similar coordinated induction was also observed for IL-1r1 chain and
cytokines IL-1a and IL-1b.
Neurotropic VSV induces a bimodal chemokine and cytokine response in the CNS
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We next examined brain chemokine and proinflammatory cytokines responses during both
the acute and recovery phases of VSV encephalitis. This study revealed that VSV generally
induced global CC chemokine and cytokine responses with bimodal kinetics with peak RNA
levels detected around 3 and 7 days PI. Representative responses are presented in Figure 4
(panel A) where CCL4 and its receptor CCR5 mRNA levels are plotted versus time. Similar
responses were observed for cytokines like Spp1 (osteopontin) and the common IL-6
signalling molecule (IL-6st, panel B) as well as CXC and CX3CL1 chemokines (panel C)).
To validate that chemokine and cytokine mRNAs were translated, we determined protein
levels for chemokines that were robustly induced at the mRNa level. Using commercial
chemokine-specific ELISA kits and the same brain samples from which the RNA profiles
were determined in Figure 4, CXCL10 protein levels in uninfected brains were 16.7 +0.96
versus 328.8 +7.7 ng/mg brain protein (p=0.001) at day 7 PI. Similarly, CCL7 protein levels
in uninfected mice were 337.8+24.7 versus 43,319+6270 pg/mg brain protein (p=0.001) also
at day 7 PI.
Role of the peripheral anti-viral immune response on chemokine and cytokine profiles in
the encephalitic brain
Bimodal kinetics may reflect a contribution by infiltrating leukocytes because VSV escapes
into the periphery following intranasal instillation (Simon et al., 2007), induces a peripheral
anti-VSV immune response where antigen persists for several months (Turner et al., 2007).
We tested this view in mice conditionally ablated of peripheral DCs where the anti-VSV
immune response is markedly suppressed (Ciavarra et al., 2006, Steel et al., 2009). Figure 5
indicates that major CC (CC12, 2, 7) and CXC (CXCL1, 9, 10, 11) chemokine responses
were generally blunted in mice depleted of peripheral DCs although CCL12 and CCL2 were
the only ones that reached statistical significance (panels A-C). Transcripts for strongly
induced proinflammatory cytokines (IFN-g, IL-1b, TNFa) were similarly blunted although
none of them reached statistical significance (panel D). Depletion of DCs reduces the
J Neuroimmunol. Author manuscript; available in PMC 2015 February 15.
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number of inflammatory cells that infiltrate the brain during the acute phase of VSV
encephalitis, an observation consistent with lowered mRNA levels for IL-2rb/IL-2rg and
Itgam/Itgb2, molecules typically found on T cells and macrophages, respectively. The
failure to completely suppress chemokine and cytokine production in the CNS may reflect
either the presence of residual brain inflammatory cells or continued production by resident
CNS cells..
Diphtheria toxin treatment suppresses VSV encephalitis without depleting putative antigen
presenting cells in the CNS
Because DT can cross the blood brain barrier (Buch et al., 2005) and microglia and bPVMs
may also express low levels of the transgenic DT receptor (Steel et al., 2008), inhibition of
brain chemokine production by DT treatment may reflect loss of these putative APC
populations with known chemokine-producing capabilities (D’Agostino et al., 2012a, del
Rio et al., 2008). In addition, the blood brain barrier does not protect choroid plexus DCs
thereby potentially exposing them to circulating DT. These cells appear to be more related to
conventional splenic CD8+ DCs than microglia based on gene expression profiles as well as
several other criteria (D’Agostino et al., 2012a). However, DT treatment did not appear to
diminish choroid plexus DCs (Figure 6, panels A, B, G), parenchymal DCs (panels C, D) or
microglia/bPVMs (panels E, F).
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Chemokine profiles in the CNS are suppressed in T cell deficient mice during the acute
phase of VSV encephalitis
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To directly test the contribution of infiltrating T cells to the brain anti-VSV chemokine and
pro-inflammatory cytokine response, B2M knockout mice were depleted of CD4+ cells and
then given VSV. Relative to normal B6 mice subjected to the same injection schedule but
given isotype-matched IgG, T cell-depleted mice mounted blunted chemokine responses to
VSV (Figure 7, panels A, B). Transcripts for chemokine receptors were also markedly
reduced in T cell-deficient mice although none reached statistical significance (panel C).
Blunted profiles were also seen for multiple cytokines and cytokine receptors (panels C, data
not shown). The failure to significantly blunt all chemokine/cytokine responses may reflect
the residual contribution of CNS resident cells because few T cells could be detected in the
brains of mice treated with anti-CD4 mAb. For example, there was an 80% reduction in the
percentage of T cells that infiltrated the brain of anti-CD4 treated mice. When absolute
numbers of T cells were calculated the reduction was even more extensive (1762 versus 52 =
97% reduction, panels E, F). Thus these data indicate that infiltrating T cells contribute
significantly to the second wave of brain chemokine/cytokine production. They further
indicate that blood-derived DCs do not contribute to this response since they remain intact
following T cell depletion.
Chemokine receptor expression on microglia and inflammatory leukocytes during VSV
encephalitis
In view of the robust and complex chemokine response induced by VSV neuroinvasion, we
sought to identify what chemokine(s) is responsible for the observed microgliosis and
accumulation of inflammatory cells. We therefore determined chemokine receptor profiles
on microglia and the infiltrate obtained from mice infected 7 days previously with VSV. It is
apparent from Figure 8 that microglia (CD45lowCD11b+F4/80+) isolated from naïve mice
did not express CCR1, CCR2, and CXCR3, whereas approximately 50% expressed CCR4
and CCR9 (Figure 8, panels a-d). The vast majority of microglia isolated during acute phase
of VSV encephalitis were CCR4+CCR9+. Although we detected a small subpopulation of
dimly CXCR3+ microglia in this experiment, in 3 other experiments microglia from VSV
infected brains remained CXCR3- (panels e-h and data not shown)). VSV did not induce
expression of CCR1 or CCR2 (panels e-h and data not shown). With the exception of CCR7,
J Neuroimmunol. Author manuscript; available in PMC 2015 February 15.
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none of the inflammatory cells (neutrophils, macrophages, T cells) expressed significant
levels of any of the other evaluated chemokine receptors (panels j-o, data not shown). Thus,
chemokines that signal via CCR1, CCR2, CCR4, CCR9 or CXCR3 do not direct
inflammatory cells into the VSV-infected brain.

4. Discussion
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Of the resident CNS cells with immunological capacity, microglia are widely regarded as
the most critical and represent approximately 10-20% of the brain parenchyma (Havenith et
al., 1998, Lawson et al., 1990, Rock et al., 2004, Santambrogio et al., 2001, Town et al.,
2005). They purportedly orchestrate inflammatory responses by the selective release of
chemokines (Meda et al., 1999) and enhance pathogen clearance as APCs (Pozzi et al.,
2005). APC function has also been ascribed to parenchymal and choroid plexus CD11c+
DCs (D’Agostino, Gottfried-Blackmore, 2012a, D’Agostino, Kwak, 2012b) as well as
bPVMs (Polfliet et al., 2002, Polfliet et al., 2001, Steel et al., 2010). However, microglia
isolated form uninfected or encephalitic brains failed to express molecules essential for
display of antigenic peptides (MHC-1/II) or delivery of costimulatory signals. VSV-specific
naïve T cells primarily receive their costimulation via B7 family members CD80/CD86
(McAdam et al., 2000) and to a lesser extent CD137 (Vinay et al., 2003) and CD40
(Andreasen et al., 2000, D’Aversa et al., 2008). Activated microglia isolated from OB, a
region where VSV accumulates and replicates, still failed to express these molecules during
the induction and acute phases of encephalitis (Forger et al., 1991). We also did not find
CCR7 expression under normal or inflammatory conditions suggesting that in the VSV
encephalitis model, microglia do not migrate to draining lymph nodes to function as APCs.
These data are in contrast with what is observed in the experimental allergic
encephalomyelitis (EAE) model where CCR7, CD86 and CD40 expression was detected on
microglia (Ponomarev et al., 2005). This difference in these two models may reflect
different inflammatory environments that impact microglia biology. Interestingly, deHass
(de Haas et al., 2008) reported regional expression of CD80, CD86 and CD40 on microglia
from uninfected brains. In our studies we assessed microglia isolated from whole brains
because VSV does not remain localized to the OB. Thus, low levels of regional expression
may have gone undetected in our studies. However, it should be noted that the one region
that we did evaluate, namely the OB, remained nega tive for costimulatory antigen
expression and this region was not evaluated in the deHass i study.
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Using a RNase protection assay, Reiss and colleagues (Ireland and Reiss, 2006) reported
that CCL1 and CXCL10 RNA transcripts were induced in the OB within one day PI with
VSV, a response that preceded the appearance of inflammatory cells in the OB. Our study
using a real-time PCR array to quantify and more completely characterize this response, are
consistent with these initial studies. A number of chemokine RNAs were elevated and likely
responsible for orchestrating the mixed cellular infiltrate characteristic of VSV encephalitis
as well as inducing microglia activation and expansion. With respect to microglia activation,
a subset constitutively expressed CCR4 and CCR9 and could therefore become rapidly
activated as soon as threshold levels of CCL3 and CCL25 were achieved, respectively. In
peripheral tissues CCL21 stimulates through CCR7 binding but in the brain CCL21
engagement of CXCR3 has been reported to activate microglia (Kallfass et al.). This is not
an alternative pathway for microglia activation because VSV did not induce expression of
CXCR3 protein on microglia. However, a role for CXCL10 in VSV encephalitis cannot be
excluded because CXCR3 mRNA is elevated, VSV is cytopathic for neurons (Faulkner et
al., 1979) and damaged neurons release CCL21 (Biber et al., 2001). We did detect
transcripts for CCL1 at 24 hours PI but unlike prior published studies (Ireland and Reiss,
2006), this response was relatively weak and not sustained (data not shown). These data
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therefore suggest that microglia activation and expansion is likely driven by multiple
chemokines signalling via CCR4 and CCR9 in response to neuroinvasion by VSV.
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Neutrophils (CD45highGr-1+F4/80-) represent the major cell type recruited into the brain
during the peak of the inflammatory response. The chemokine(s) responsible for their influx
remains to be identified. Both CCL3 and CCL25 are reported to recruits monocytes/
macrophages (Nakamoto et al., 2012, Tran et al., 1998) and as discussed above RNA
transcripts for these chemokines as well as their receptors CCR4 and CCR9 were elevated
on 1 day PI. However, infiltrating neutrophils did not express CCR1, 2, 4, 9 and only a
variable subpopulation (0-25%) expressed CXCR3 in the encephalitic brain. T cells (CD4
and CD8+) also make a significant contribution to the infiltrate. Although transcripts for the
T cell chemokine CCL17 were rapidly induced and sustained during VSV encephalitis,
infiltrating T cells did not express its receptor CCR4 (manuscript in preparation). The most
likely candidate for the directed migration of inflammatory cells into the brain parenchyma
is CCR7. As demonstrated herein, CCR7 was expressed on the majority of inflammatory
cells on 7 days PI and preliminary studies indicate that mRNA for one of its ligands,
CCL19, was rapidly induced (5-fold induction) at 48 hours PI. Furthermore, elevated
CCL19 transcript levels remained sustained throughout the acute and recovery phases of
VSV encephalitis (data not shown). Ongoing neutralization studies are designed to
determine th e extent to the VSV-induced infiltrate is CCR7-dependent.
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At the peak of the inflammatory response (days 6-8) chemokine responses were more robust
relative to day 1 PI with additional chemokines and cytokines recruited into the response.
We observed similar blunted chemokine and cytokine responses in the brains of VSV
infected mice on 7 days PI following conditional DC ablation or T cell depletion. These
similar profiles were likely due to the markedly reduced expansion of T cells in peripheral
lymphoid organs in mice rendered deficient of DCs (Steel et al., 2009). Thus, the DCdepleted host generates fewer activated T cells including tetramer+ VSV-specific T cells
that can subsequently invade the VSV infected brain. T cells most likely represent the
primary cellular source of chemokines and proinflammatory cytokines at this time point
although a T cell-glial interaction essential for glial chemokine production cannot be
excluded. Residual chemokine and cytokine production in mice depleted of T cells may
reflect the ongoing contribution of CNS resident cells. Consistent with this view, a number
of viral pathogens have been shown to induce cytokine production in resident astrocytes
(Phares et al., 2013), microglia (Marques et al., 2006) and neurons (Horta et al., 2011).
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In summary, we demonstrate herein that VSV neuroinvasion induces a rapid and complex
bimodal brain chemokine and proinflammatory cytokine response. CNS resident and
infiltrating T cells likely contribute to the initial and second wave of chemokine/cytokine
production, respectively. In the encephalitic brain microglia rapidly convert from a resting
(CD45lowCD11b+F4/80+Gr-1-CD80-CD86-CD40L-PD-1-PD-L1/2-CCR1-CCR2-CR4±
(~50%)CCR7-CCR9+(~50%)CXCR3-) to an activated phenotype that includes CCR4 and
CCR9 expression on the vast majority of microglia as well as previously reported inductions
(MHC-1/II, PD-1). We suggest that constitutive expression of CCR4 and CCR9 may allow
microglia to respond quickly to rapidly induced CCR4 (CCL2, 3, 17, 22) and CCR9
(CCL25) ligands, respectively. Although activated microglia express MHC-I/II antigens,
their precise role in the anti-VSV adaptive immune response remains to be clarified. We also
suggest that the accumulation of a robust mixed cellular infiltrate most likely reflects the
sustained production of brain CCL19 and CCR7 expression on brain inflammatory cells.
Thus, clearance of this viral pathogen requires the coordinated induction of a brain
inflammatory response as well as a peripheral antiviral adaptive immune response to insure
efficient viral clearance from the CNS.
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•

We study the murine VSV encephalitis model to understand how a neurotropic
viral pathogen is cleared from the brain

•

Neuroinvasion induces chemokine receptor expression on microglia but not costimulatory molecules

•

Chemokine and proinflammatory cytokine responses in the CNS are robust,
complex and biphasic

•

Second wave of brain chemokine/cytokine production is dependent on a
peripheral immune response and infiltrating T cells
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Figure 1.

Phenotypic characterization of microglia and inflammatory cells isolated during the acute
phase of VSV encephalitis. DTRTg F1 mice were given DT one day before and after
intranasal application of VSV. Control non-DTRTg mice were either not infected (naïve) or
given just VSV (4-5 mice/group). Six days PI, brains from each group were pooled, minced
and single cell suspension of brain tissue banded on a 70% Percoll cushion. Microglia and
brain leukocytes banded at the 30-70% Percoll interface were collected, labeled with the
indicated mAbs and then phenotyped by 4-color flow cytometry. Microglia were gated as
CD45low/intCD11b+ (panel A, R1 gate), whereas inflammatory cells were defined as
CD45highCD11b+ cells (R2 gate). Co-expression of the indicated molecules on gated
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microglia (B) or inflammatory cells (C) isolated from brains of either normal or DCdepleted, VSV infected mice.
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Figure 2.

Failure of OB microglia to express B7 costimulatory family members during the induction
phase of VSV encephalitis. DTRTgF1 mice were either untreated (9 mice) or depleted of
peripheral DCs (3 mice) and then given an intranasal application of VSV (2×105 PFU/
mouse). A third cohort (6 mice) was neither DT treated nor VSV infected (mock). Three
days PI mice were euthanized and leukocytes isolated either from the OB or the remaining
brain (-OB). (panel A) Microglia were defined as CD45lowCD11b+ (R1) cells and assessed
for co-expression of the indicated costimulatory molecules on OB microglia from mock
infected (panels a-e), VSV infected (panels f-j) and VSV infected and DT treated (panels ko). (panel B) Distribution of B7 family members on microglia isolated from either the OB or
whole brain devoid of OB (-OB). Microglia were phenotyped in two independent
experiments and data expressed as the mean ±SEM of the indicated family member.
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Figure 3.

VSV infection triggers rapid and multiple changes in brain chemokine and proinflammatory
cytokine RNA profiles within 24hours of intranasal infection. Mice (5/group) were given a
single intranasal application of 5 × 104 PFU of VSV and one day PI euthanized, perfused
with PBS and whole brain homogenates prepared. RNA was isolated from individual mice,
pooled and subsequently analyzed for chemokine and proinflammatory cytokine RNA levels
using a commercial inflammatory cytokine qPCR array. Control (uninfected) mice were
treated similarly and their brain RNA levels used to calculate fold increases/decreases in
infected mice. Data represent the means +SEM of two independent experiments.
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Figure 4.

Chemokine and proinflammatory cytokine responses display bimodal kinetics during VSV
encephalitis. . Mice (3-5 mice/group) were given a single intranasal application of VSV and
at the indicated time points, euthanized, perfused and whole brain homogenates prepared for
subsequent analysis. RNA was isolated from each mouse, pooled and chemokine and
cytokine profiles determiend as previously described.
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Figure 5.

Ablation of peripheral dendritic cells suppresses chemokine RNA levels in the brain during
the acute phase of VSV encephalitis. DTRTgF1 mice were either untreated or treated with
DT to deplete DCs and then infected intranasally with VSV. Six days PI mice were
euthanized, perfused with cold PBS and brains evaluated for chemokine and
proinflammatory cytokine mRNA levels by qPCR array. For each group individual profiles
(3 mice/group) were determined and fold change calculated as previously described. Data
shown are the mean ± SEM. Asterisks indicate significant differences (*p = <0.05, **p=
<0.01)
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Figure 6.

Brain dendritic cells and perivascular macrophages remain following treatment with
diphtheria toxin. DTRTgF1 mice were either untreated or given two doses of DT following
our standard protocol. One day after the last injection, mice were euthanized and perfused
with ~30mls cold PBS. Brains were excised, halved along the longitudinal cerebral fissure
dividing the brain into left and right hemispheres and half either snap frozen or fixed with
10% formalin. Frozen tissues were subsequently sectioned, stained with either CD11c
(panels A-D) or F4/80 mAbs (panels E and F) followed by biotinylated secondary antibodies
and avidin-biotinylated peroxidase (ABC kit, Vector Laboratories). Sagittal sections
presented in this figure were obtained from 0-1.93mm from the longitudinal cerebral fissure.
J Neuroimmunol. Author manuscript; available in PMC 2015 February 15.

Steel et al.

Page 20

NIH-PA Author Manuscript

Panels illustrate typical staining patterns of brain sections obtained from DTRTg mice
treated with either PBS (panels A, C, E) or DT (B, D, F). Darkly stained F4/80+ cells in
panels E and F are bPVMs (arrows). Lightly stained F4/80+ cells are parenchymal
microglia. Frozen sections containing choroid plexus from PBS (panel A) and DT (panel B)
injected mice (3-5 mice/group) were scored blindly for CD11+ cells and data expressed as
mean ±SEM (panel G). Two sections of the choroid plexus for each mouse were scored. Cell
counts were not statistically different between treatment groups.
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T cell deficient mice mount blunted chemokine response during the acute phase of VSV
encephalitis. MHC class I-deficient B6 mice (CD8 T cell deficient) were rendered CD4deficient using a depleting anti-CD4 mAb (details Materials and Methods). Control B6 mice
were subjected to the same schedule except infused with a matched isotype control mAb.
Seven days PI mice were euthanized, perfused with cold PBS and spleen and brains
removed for flow cytometric and chemokine analysis, respectively. (panels A-D) Mean fold
increases/decreases in RNA levels relative to levels detected in uninfected whole brains.
Asterisks indicates significant differences (*p= <0.05, **p= <0.01). (panels E, F) Infiltrating
leukocytes were enriched from whole brain homogenates from mice treated with isotype
control (panel E) or anti-CD4 mAb (panel F). Brain leukocytes were isolated, stained with
anti-CD4 mAb and analysed by flow cytometry (see Materials and Methods). Percent CD4+
T cells in leukocyte gate are indicated.
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Figure 8.

VSV encephalitis is associated with a selective induction of chemokine receptors on
microglia. B6 mice were given a single application of VSV and 7 days PI, mice were
euthanized, perfused and whole brain homogenates prepared. Brain leukocytes were
enriched on Percoll gradients and labelled with the indicated mAbs. (panel A) Leukocytes
were isolated from uninfected (panels a-d) or VSV-infected brains (panels e-h) and
identified by forward and side scatter characteristics. Microglia were gated as
CD45lowCD11b+ cells (region 1, R1) and assessed for expression of the indicated
chemokine receptors. (panel B) Inflammatory cells were identified in the CD45highCD11b+
gate (panel e, R2) and within this gate granulocytes defined as Gr−1+F4/80-(panel i, R3).
Chemokine receptor profiles were then examined on this population (panels j-l) as wells as a
fourth population (R4) of double positive cells (Gr −1+ F4/80+) presumed to be
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macrophages (panels m-o). This experiment was repeated a second time and yielded similar
results.
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